1. Home
  2. UCAR vs POM Comparison

UCAR vs POM Comparison

Compare UCAR & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U Power Limited

UCAR

U Power Limited

N/A

Current Price

$3.28

Market Cap

6.9M

ML Signal

N/A

Logo POMDOCTOR LIMITED American Depositary Shares

POM

POMDOCTOR LIMITED American Depositary Shares

SELL

Current Price

$1.97

Market Cap

5.9M

ML Signal

SELL

Company Overview

Basic Information
Metric
UCAR
POM
Founded
2013
2015
Country
China
China
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Other Specialty Stores
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
5.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
UCAR
POM
Price
$3.28
$1.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4K
★ 1.3M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.06
52 Week High
$8.99
$6.43

Technical Indicators

Market Signals
Indicator
UCAR
POM
Relative Strength Index (RSI) 43.46 76.11
Support Level $1.05 $0.15
Resistance Level $4.19 N/A
Average True Range (ATR) 0.19 0.32
MACD -0.15 0.12
Stochastic Oscillator 3.49 66.70

Price Performance

Historical Comparison
UCAR
POM

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: